News & Perspective

Oct 03, 2016

Oct 03, 2016

News Scan for Oct 03, 2016

MRSA in UK pork
Online antibiotic Rx
Chikungunya increase
Anthrax vaccine funds
Yellow fever vaccine

Nov 24, 2015

Nov 24, 2015

News Scan for Nov 24, 2015

Chicken salad E coli outbreak
Hawaii dengue outbreak
Postexposure BioThrax approved
Malaria gene replacement

Jun 19, 2015

Jun 19, 2015

News Scan for Jun 19, 2015

B anthracis kill failure
Ebola drug disappoints
Salmonella from geckos
Diagnosing Zika virus
Dengue in Yemen

Sep 09, 2014

Sep 09, 2014

News Scan for Sep 09, 2014

ICU infections in kids
Heat-tolerant anthrax vaccine
Ohio measles over
Berry-linked hepatitis
Vectorborne illness control

Jul 24, 2014

Jul 24, 2014

News Scan for Jul 24, 2014

CDC lab biosafety update
GM mosquitoes to fight dengue
GSK's malaria vaccine
Cholera vaccination in Haiti
Global hepatitis progress

Oct 14, 2011

Oct 14, 2011

NIH contracts target broad-spectrum therapies for bioterror threats

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

Pages

Sort Results

 

Narrow results

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»